Drug Acetylation in Liver Disease
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 34 (3) , 219-226
- https://doi.org/10.2165/00003088-199834030-00004
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Relationship Between Antipyrine Metabolism and Acetylation Phenotype in Health and Chronic Liver DiseasesThe Journal of Clinical Pharmacology, 1995
- Caffeine metabolism in patients with chronic liver diseaseScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Acetylator Genotype-Dependent Formation of 2-Aminofluorene-Hemoglobin Adducts in Rapid and Slow Acetylator Syrian Hamsters Congenic at the NAT2 LocusToxicology and Applied Pharmacology, 1994
- Clinical Pharmacokinetics in Patients with Liver DiseaseClinical Pharmacokinetics, 1991
- Acetylator genotype and arylamine-induced carcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977
- Elimination of Para-Aminosalicylic Acid in Patients with Liver Disease and Renal InsufficiencyChemotherapy, 1977
- Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver diseaseGut, 1972
- PHENYLBUTAZONE AND ISONIAZID METABOLISM IN PATIENTS WITH LIVER DISEASE IN RELATION TO PREVIOUS DRUG THERAPYThe Lancet, 1968